ECA/PQG Working Group finalises GDP Interpretation Guide

Recommendation
9 September 2025
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
The last three chapters of an interpretation of the EU Good Distribution Practice Guide (GDP) have been published jointly by the ECA Foundation Working Group on GDP and the Pharmaceutical Quality Group (PQG). Both organisations joined forces to develop a Guide intended to help colleagues in industry with the implementation of the EU GDP Guideline.
The new publications focus on Chapter 3 Premises and Equipment, Chapter 4 Documentation and Chapter 10 Brokers. As with the other guidance documents of the working group, these elaborate the rationale for the various subchapters and give guidance for interpretation and implementation.
The guidance on the interpretation and implementation of Chapter 3 contains two appendices; a template for a temperature mapping protocol and a template for the respecive report.
The new chapters complement the already published chapters:
- Chapter 1: Quality Management
- Chapter 2: Personnel
- Chapter 5: Operations
- Chapter 6: Complaints, Returns, Suspected Falsified Medicinal Products & Medicinal Product Recalls
- Chapter 7: Outsourced Activities
- Chapter 8: Self Inspections
- Chapter 9: Transportation
All chapters as well as the new Code for Practice for Responsible Persons can be downloaded from the ECA GDP Group Webpage after registration.
Related GMP News
10.06.2025Stimuli Article Proposes Revision of USP Definition of Controlled Room Temperature (CRT)
10.06.2025New MHRA Blog Post: Supplying Medicines to Ships, Aircraft and Oil Platforms
10.06.2025Questions and Answers from the ECA Webinar "GDP Update 2025" - Part 3
10.06.2025Meet the GDPA Board Members at the GDP Forum in Barcelona
10.06.2025Swissmedic Technical Interpretation: What Counts as a Major Change in GDP?
10.06.2025MHRA informes about Validity Date of UK issued GDP Certificates